Market Place
Sourcing Support
Tarsus Launches First DTC TV Campaign For XDEMVY® Solution
17 Oct 2024 //
GLOBENEWSWIRE
Elanco Receives FDA Approval For Credelio Quattro Canine Parasiticide
07 Oct 2024 //
PR NEWSWIRE
Tarsus To Participate In UBS Ophthalmology Day 2024
25 Sep 2024 //
GLOBENEWSWIRE
Tarsus To Participate In Wells Fargo Securities Healthcare Conference
28 Aug 2024 //
GLOBENEWSWIRE
Tarsus To Report Q2 2024 Financial Results On August 8, 2024
29 Jul 2024 //
GLOBENEWSWIRE
Tarsus Q1 2024 Results, Business Achievements
08 May 2024 //
GLOBENEWSWIRE
Tarsus Introduces Mite Party Campaign for XDEMVY
05 Mar 2024 //
GLOBENEWSWIRE
Tarsus Announces Positive Topline Results from Carpo
22 Feb 2024 //
GLOBENEWSWIRE
Now Available-XDEMVY, First and Only Approved Treatment for Demodex Blepharitis
24 Aug 2023 //
GLOBENEWSWIRE
FDA clears Tarsus` Xdemvy as first treatment for common eyelid disease
26 Jul 2023 //
FIERCE PHARMA
Tarsus launches ‘Look at the Lids’ campaign for painful eyelid condition
30 Sep 2022 //
FIERCEPHARMA
Tarsus Submits New Drug Application to the FDA for TP-03 for the Treatment
07 Sep 2022 //
GLOBENEWSWIRE
Eyelid mites no match for Tarsus eye drop, teeing up FDA push
02 May 2022 //
FIERCEBIOTECH
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.